ニューヨーク・タイムズのインスタグラム(nytimes) - 11月19日 01時17分

The drug maker Pfizer said on Wednesday that its coronavirus vaccine was 95% effective and had no serious side effects — the first set of complete results from a late-stage vaccine trial as Covid-19 cases skyrocket around the globe.

The drug maker said that the vaccine prevented both mild and serious forms of Covid-19 and was effective in older adults, who are more vulnerable.

Pfizer, which developed the vaccine with its partner BioNTech, said the companies planned to apply to the @fda for emergency authorization “within days.”

If the FDA authorizes the 2-dose vaccine, Pfizer has said that it could have up to 50 million doses available by the end of the year, and up to 1.3 billion by the end of next year.

However, only about half of its supply will go to the U.S. this year, or enough for about 12.5 million people — a sliver of the American population of 330 million. Federal health officials have said the first doses of the vaccines will most likely go to groups like health care workers who are at high risk for exposure, as well as to people who are most vulnerable to the disease, such as older people.

Tap the link in our bio to read the latest updates.

[BIHAKUEN]UVシールド(UVShield)

>> 飲む日焼け止め！「UVシールド」を購入する